|
Gene: PINLYP |
Gene summary for PINLYP |
Gene summary. |
Gene information | Species | Human | Gene symbol | PINLYP | Gene ID | 390940 |
Gene name | phospholipase A2 inhibitor and LY6/PLAUR domain containing | |
Gene Alias | PINLYP | |
Cytomap | 19q13.31 | |
Gene Type | protein-coding | GO ID | GO:0008150 | UniProtAcc | A6NC86 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
390940 | PINLYP | C06 | Human | Oral cavity | OSCC | 4.71e-03 | 7.16e-01 | 0.2699 |
390940 | PINLYP | C08 | Human | Oral cavity | OSCC | 2.26e-02 | 1.21e-01 | 0.1919 |
390940 | PINLYP | LN46 | Human | Oral cavity | OSCC | 2.41e-03 | 2.09e-01 | 0.1666 |
390940 | PINLYP | LP15 | Human | Oral cavity | LP | 3.12e-02 | 9.31e-01 | 0.2174 |
390940 | PINLYP | LP17 | Human | Oral cavity | LP | 1.38e-04 | 6.44e-01 | 0.2349 |
390940 | PINLYP | SYSMH2 | Human | Oral cavity | OSCC | 8.16e-04 | 1.50e-01 | 0.2326 |
390940 | PINLYP | SYSMH3 | Human | Oral cavity | OSCC | 2.38e-02 | 1.07e-01 | 0.2442 |
390940 | PINLYP | SYSMH4 | Human | Oral cavity | OSCC | 1.50e-06 | 1.42e-01 | 0.1226 |
Page: 1 2 3 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PINLYP | SNV | Missense_Mutation | novel | c.149C>T | p.Pro50Leu | p.P50L | A6NC86 | protein_coding | deleterious(0.01) | probably_damaging(0.966) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PINLYP | SNV | Missense_Mutation | novel | c.603N>A | p.Met201Ile | p.M201I | A6NC86 | protein_coding | deleterious(0.02) | benign(0.003) | TCGA-D1-A2G0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PINLYP | deletion | Frame_Shift_Del | novel | c.339delN | p.Gly114AlafsTer7 | p.G114Afs*7 | A6NC86 | protein_coding | TCGA-B5-A5OC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Chemotherapy | cisplatin | SD |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |